Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record now presents details of the CX-188 Phase 1 trial, including its study design, eligibility criteria, treatment arms, outcomes, locations, and record dates, instead of an error page.
    Difference
    34%
    Check dated 2026-11-09T13:13:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2; the study record remains unavailable behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-02T12:41:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The clinical trial record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T14:10:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:12:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:56.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error when attempting to view the study record, blocking access to the study content on ClinicalTrials.gov.
    Difference
    15%
    Check dated 2026-09-21T22:09:19.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.